
Opinion|Videos|July 25, 2024
Barriers to Implementing ctDNA Testing
Panelists analyze observed obstacles to implementing routine circulating tumor DNA testing as a standard of care, while offering strategies to overcome these challenges.
Advertisement
Episodes in this series

- What are some barriers that have been observed to implementing routine standard-of-care ctDNA testing?
- Do barriers differ between academic and community settings?
- Do you have any practical tips to navigate these barriers to implementation?
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Matching Neoadjuvant Therapy to Tumor Genomics in High-Risk Prostate Cancer
2
FDA Approves Perioperative Durvalumab/Enfortumab Vedotin in MIBC
3
Subsequent Therapy May Have Narrowed the Overall Survival Gap in LITESPARK-011
4
Second-Line Options and Selecting Ipilimumab Plus Nivolumab in RCC
5

